I had severe left-sided UC with transverse involvement, on 10mg/kg Q8wks Remicade and one year into with extensive mucosal healing/reduction in pseudopolyps and my UC is quiescent... wish to hell I would’ve been able to go on Entyvio instead when TNF-naive since it takes much longer and my disease process was to severe they didn’t consider it..
</3

So since I’m NOT TNF-naive now if I switched would risk of lost efficacy of Entyvio outweigh risk reduction from adverse effects of Remicade... PLEASE give me more than a one sentence reply and consider the question as if it was coming from your daughter... I don’t want infusion reaction or antibodies, I don’t want lymphoma, I’d rather be on Entyvio while pregnant than Remicade since it’s therapeutic effects are more better targeted... but I also don’t want to screw around switching biologics if it would throw out my remission and I wouldn’t be able to achieve current improved clinical presentation again after. Thank you so much for your time from the bottom of my heart and God bless.